Cargando…

PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer

Emerging evidence has shown that adding poly(ADP-ribose) polymerase (PARP) inhibitors to chemotherapy regimens is superior to the control regimens alone in BRCA1-mutated triple-negative breast cancer (TNBC) patients, but their underlying mechanisms have not been fully elucidated. In this study, usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Wei, Tang, Lin, Xu, Yumei, Xu, Jing, Zhang, Wenwen, Xie, Hui, Wang, Shui, Guan, Xiaoxiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296748/ https://www.ncbi.nlm.nih.gov/pubmed/28176879 http://dx.doi.org/10.1038/srep42319

Ejemplares similares

Corrigendum: PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer
por: Song, Wei, et al.
Publicado: (2017)

The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer
por: Luo, Jiayan, et al.
Publicado: (2016)

MiR-181a targets STING to drive PARP inhibitor resistance in BRCA- mutated triple-negative breast cancer and ovarian cancer
por: Bustos, Matias A., et al.
Publicado: (2023)

Loss of MiR-664 Expression Enhances Cutaneous Malignant Melanoma Proliferation by Upregulating PLP2
por: Ding, Zhenhua, et al.
Publicado: (2015)

Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
por: Park, Hyung Seok, et al.
Publicado: (2019)

Expression of miR-664 and miR-184 on proliferation, apoptosis and migration of osteosarcoma cells
por: Tao, Pengfei, et al.
Publicado: (2019)

BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
por: Jacot, William, et al.
Publicado: (2020)

Upregulation of miR-664a-3p Ameliorates Calcific Aortic Valve Disease by Inhibiting the BMP2 Signaling Pathway
por: Jiang, Yun, et al.
Publicado: (2022)

miR‐664a‐3p functions as an oncogene by targeting Hippo pathway in the development of gastric cancer
por: Wang, Lu, et al.
Publicado: (2019)

Combining PARP inhibitors and platinum-based chemotherapy in metastatic triple negative and/or BRCA-associated breast cancer
por: Molto Valiente, Consolacion, et al.
Publicado: (2023)

The long non‐coding RNA landscape in triple‐negative breast cancer
por: Zhang, Wenwen, et al.
Publicado: (2020)

Acarbose Reduces Blood Glucose by Activating miR-10a-5p and miR-664 in Diabetic Rats
por: Zhang, Qian, et al.
Publicado: (2013)

miR-664b-3p inhibits colon cell carcinoma via negatively regulating Budding uninhibited by benzimidazole 3
por: Zhao, Liang-Yu, et al.
Publicado: (2022)

Overexpression of miR-664 is associated with poor overall survival and accelerates cell proliferation, migration and invasion in hepatocellular carcinoma
por: Wang, Xianming, et al.
Publicado: (2019)

Correction: Acarbose Reduces Blood Glucose by Activating miR-10a-5p and miR-664 in Diabetic Rats
por: Zhang, Qian, et al.
Publicado: (2014)

Combining Carbon-Ion Irradiation and PARP Inhibitor, Olaparib Efficiently Kills BRCA1-Mutated Triple-Negative Breast Cancer Cells
por: Kawanishi, Miki, et al.
Publicado: (2022)

Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
por: Deng, Ling, et al.
Publicado: (2017)

BCL11A confers cell invasion and migration in androgen receptor-positive triple-negative breast cancer
por: Wang, Xin, et al.
Publicado: (2020)

Expression of miR-664-3p in Osteosarcoma and Its Effects on the Proliferation and Apoptosis of Osteosarcoma Cells
por: LI, Ye, et al.
Publicado: (2019)

Photocontrolled apoptosis induction using precursor miR-664a and an RNA carrier-conjugated with photosensitizer
por: Watanabe, Kazunori, et al.
Publicado: (2021)

BRCA2 Mutations and Triple-Negative Breast Cancer
por: Meyer, Peter, et al.
Publicado: (2012)

Therapeutic landscape in mutational triple negative breast cancer
por: Shi, Yaqin, et al.
Publicado: (2018)

MiR‐664‐3p suppresses osteoblast differentiation and impairs bone formation via targeting Smad4 and Osterix
por: Xu, Yuexin, et al.
Publicado: (2021)

MicroRNAs miR-203-3p, miR-664-3p and miR-708-5p are associated with median strain lifespan in mice
por: Lee, Benjamin P., et al.
Publicado: (2017)

DAXX, as a Tumor Suppressor, Impacts DNA Damage Repair and Sensitizes BRCA-Proficient TNBC Cells to PARP Inhibitors()
por: Shi, Yaqin, et al.
Publicado: (2019)

ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
por: Song, Wei, et al.
Publicado: (2017)

miR‐129‐2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4
por: Zhou, Weizheng, et al.
Publicado: (2022)

Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers
por: Garcia, Amandine I, et al.
Publicado: (2011)

MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin
por: Huang, Nunu, et al.
Publicado: (2015)

BRCA1 mutation in the Triple- Negative Breast Cancer Group
por: Maksimenko, Jelena, et al.
Publicado: (2012)

Modulation of Early Mitotic Inhibitor 1 (EMI1) depletion on the sensitivity of PARP inhibitors in BRCA1 mutated triple-negative breast cancer cells
por: Moustafa, Dina, et al.
Publicado: (2021)

miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma
por: Xu, Meng, et al.
Publicado: (2014)

MiR-664a-3p expression in patients with obstructive sleep apnea: A potential marker of atherosclerosis
por: Li, Kun, et al.
Publicado: (2018)

The role of PARP inhibitors in BRCA mutated pancreatic cancer
por: Chi, Jeffrey, et al.
Publicado: (2021)

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
por: Jiang, Tingting, et al.
Publicado: (2016)

Autoimmune response to PARP and BRCA1/BRCA2 in cancer
por: Zhu, Qing, et al.
Publicado: (2015)

Translating the role of PARP inhibitors in triple-negative breast cancer
por: Beniey, Michèle, et al.
Publicado: (2019)

Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
por: Pogoda, Katarzyna, et al.
Publicado: (2020)

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
por: Glodzik, Dominik, et al.
Publicado: (2020)

Association of miR-608 rs4919510 polymorphism and cancer risk: a meta-analysis based on 13,664 subjects
por: Liu, Huiquan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s34v6jongbklnlb91k0nnm74e2